Abstract-Protection of salvinorin B as standard alkoxyalkyl ethers yielded highly potent j opioid receptor agonists. Ethoxymethyl ether 6 is among the most potent and selective j agonists reported to date. Fluoroethoxymethyl ether 11 is the first potent, selective fluorinated j ligand, with potential use in MRI and PET studies. Further enlargement of the alkoxy group, alkylation of the acetal carbon, or heteroatom substitution all reduced activity. These protecting groups may prove useful in related work not only by enabling the use of harsher synthetic conditions, but potentially by optimizing the potency of the products.
Introduction
Salvinorin A (1) is a potent and selective naturally-occurring j (kappa) opioid. 1 As one of very few reported nonnitrogenous opioids, 2 salvinorin A has created new opportunities for understanding the mechanisms of ligand binding at opioid receptors, which might facilitate drug discovery. One objective has been the development of selective antagonists or partial agonists at j opioid receptors; such agents have potential utility in the treatment of depression or mania, 3 debilitating conditions for which all current treatments have significant limitations (e.g., poor efficacy, delayed onset, marked side effects). Many derivatives of 1 have now been tested at opioid receptors. 4 Binding affinity and potency are almost invariably reduced; very few derivatives exhibit potency comparable to 1. Most active derivatives, like the parent compound, are full agonists, but recently partial agonists and antagonists have been reported. 4, 5 This is potentially significant, since the few available selective j antagonists exhibit extremely slow onset ($24 h) and long duration of action (>3 weeks), 6 which complicates their use in the study or treatment of psychiatric conditions such as depression. 7 However, the modifications which appear to confer partial agonist and antagonist activities on salvinorin derivatives also dramatically reduce binding affinity and selectivity; 4, 5 methods to optimize these parameters would therefore be useful. To date the most thoroughly studied functional group of 1 is the C-2 acetate. Interestingly, while deacetylation (giving 2) dramatically lowers affinity and potency, 8 demethyl and deoxy analogues 3 9 and 4b 8 each show only modestly reduced affinity. This suggests that these two portions of the acetate may be involved in separate, synergistic interactions with the receptor. Only one derivative with greater potency than 1 has been reported to date: methoxymethyl (MOM) ether 5. 10 The increased affinity of 5 may be due to the additional sp 3 -hybridized oxygen, especially considering the lower affinity of its closest sp 2 -hybridized analogue, 3. Alternatively, the terminal methyl group of 5 might create an additional interaction, which could be explored by the substitution of other alkoxy groups. A related question is whether methylation of the acetal carbon would further increase potency, as with formate 3. In hopes of optimizing the C-2 substituent, we explored these questions using related protecting groups.
Chemistry
Deacetylation 11 of 1, isolated from dried Salvia divinorum leaves as previously described, 12 gave 2. MOM ether 5 was prepared from 2 and CH 3 OCH 2 Cl as previously described. 13 The published 1 H NMR data 13 required amendment. The molecular formula, not previously established, was confirmed by HRMS. The ethoxymethyl (EOM) ether 6 and several other standard alkoxymethyl ethers were prepared similarly (Scheme 1; see Table 1 for individual structures). 14 For the more unusual alkoxymethyl ethers 7-12, the corresponding chloromethyl ethers were expensive or hard to obtain. Rather than prepare and purify these volatile carcinogens, an alternative route was used. Methylthiomethyl ether 16 was prepared from 2 using Ac 2 O and AcOH in Me 2 SO (Scheme 1). 15 When following the published procedure, side reactions resulted in poor yields, but we found that these were suppressed by a large excess of AcOH. The alkoxymethyl compounds 7-12 were then produced by alcoholysis of 16, using N-iodosuccinimide (NIS) and catalytic TfOH with the appropriate alcohol. 16 Although low-yielding (<40%), this route offers access to a wide range of products from a common intermediate and readily available alcohols. The NIS route was also employed for the 2-methoxyethoxymethyl (MEM) ether 13. Although the corresponding chloromethyl ether is readily available, 13 is difficult to separate from residual starting material Compounds 18, 19, and 20 were prepared using ethoxyethene, 2-methoxypropene, and 3,4-dihydro-2H-pyran, respectively, with catalytic p-TsOH or PPTS (Scheme 2).
14 The two epimers of 18 were separated with difficulty by repeated flash chromatography; complete separation was not achieved. Epimerization also occurred in CDCl 3 , so NMR data were collected in C 6 D 6 . The relative configurations of 18a and b were not determined. Tetrahydropyranyl ether 20 was also formed as an epimeric mixture, but only one epimer could be isolated after chromatography on silica gel, contaminated with a small amount of the other. Again, the configuration at the acetal carbon is unknown. For NMR, CDCl 3 filtered through basic Al 2 O 3 was satisfactory for brief exposures, but for longer experiments C 6 D 6 was required.
Results and discussion
Binding affinities and potencies at the j receptor are shown in Table 1 . All compounds were full agonists, with efficacy approximately equal to that of U50,488H. All compounds except 14 showed submicromolar affinity and potency, generally in the low nanomolar range. None of the compounds bound to l or d receptors (K i > 1 lM). This series as a whole shows markedly higher affinity and selectivity than previously reported series of derivatives of 1.
Among the n-alkoxymethyl ethers 5-8, the ethyl substituent was optimal (6), conferring extreme (subnanomolar) affinity and potency. Given the lack of l and d affinity, this compound is therefore also extremely selective (l/j and d/j > 3000). There have been very few reports of compounds with l/j selectivity over 1000. 20 Ethoxymethyl ether 6 is thus among the most potent and selective j opioids reported to date. While the naltrexone derivative nalfurafine (TRK-820) is more potent still (EC 50 = 0.025 nM under the same conditions), this compound shows much lower selectivity (l/j < 100). 21 The potency of the MOM ether 5, while lower than 6, was nonetheless higher than 1 or U50,488H, as previously reported. 10 The selectivity of this compound, which has not previously been quantified, is thus also extremely high (l/j and d/j > 1600). Further extension of the alkyl chain reduced activity, but the propoxymethyl and butoxymethyl ethers 7 and 8 retained activity comparable to 1. The same trend was previously reported in the alkyl ether 8 and ester 22 series, but with strikingly inferior absolute values. This provides further confirmation that substitution of oxygen in this position dramatically increases binding affinity. However, the increase in binding affinity from 5 to 6 suggests that an additional interaction involving the terminal alkyl group also contributes to the extremely high affinities of these compounds. For instance, the receptor may possess a hydrophobic pocket just deep enough to accommodate an ethyl group.
Branching of the alkyl chain was not as well tolerated as elongation; the isopropoxy and tert-butoxy compounds 9 and 10 showed a steep, progressive loss of activity relative to 6. MEM ether 13, with the same chain length as butoxymethyl ether 8, showed lower affinity than that compound. Larger protecting groups were also poorly tolerated: the 2-(trimethylsilyl)ethoxymethyl (SEM, 14) and benzyloxymethyl (BOM, 15) ethers were the least active compounds in the series.
2-Fluoroethoxymethyl ether 11 showed potency and affinity approximately equal to salvinorin A (1) itself. To our knowledge, 11 is the first potent, selective fluorinated ligand at the j opioid receptor to be reported in the peer-reviewed literature. This is potentially significant, since the presence of fluorine permits in vivo imaging through 19 F magnetic resonance imaging (MRI), or (with 18 F labeling) positron emission tomography (PET). 23 Should labeling prove feasible, compound 11 has important potential advantages over the existing [
11 C]-labeled PET ligand, GR103545. 24 Although often described as j-selective, this compound and its racemate in fact display higher affinity for l than j receptors (l/j = 0.5). 25 By contrast, compound 11 is highly selective (l/j > 500). Another potential advantage of 11 is that the half-life of 18 F is five times longer than that of 11 C, which increases sensitivity and allows a wider range of experiments.
Heteroatom substitution at the alkoxy group reduced activity. Methylthiomethyl ether 16 showed much lower potency than 5, comparable to the previously reported propyl ether 4c of equal chain length (EC 50 = 67 nM under the same conditions). 8 The potency of fluoromethyl ether 17 was also greatly reduced relative to 5. Although fluorine is widely regarded as isosteric with hydrogen, it is in fact much closer in size to oxygen, and can serve as an effective bioisostere for hydroxy and methoxy groups. 26 Thus, while many would regard 17 as a bioisostere for the methyl ether 4a, it is in fact closer to 5. Direct
Scheme 2. Synthesis of other alkoxyalkyl ethers. * Configuration unknown.
comparison of fluorine and oxygen is confounded, however, by the terminal methyl substituent in 5, which as discussed above appears to contribute to that compound's potency. An indirect comparison is nonetheless possible. The potency of 17 was similar to that of ethyl ether 4b (EC 50 = 18 nM). 8 Thus, whereas substitution of oxygen for C-2 of the propyl and butyl ethers (giving 5 and 6) dramatically increases activity, substitution of fluorine for C-2 of the ethyl ether (giving 17) has little effect. These results for 16 and 17 suggest that the alkoxymethyl group may act as an H-bond acceptor, since organic fluorine is a very poor H-bond acceptor, 27 and sulfur is not an acceptor.
Contrary to the trend observed with the formate 3, methyl substitution of the acetal carbon dramatically lowered affinity. Compound 18 (the methyl analogue of 6) had at least 20-fold lower affinity, while 19 (the dimethyl analogue of 5) exhibited a greater than 100-fold reduction. This implies that this series of compounds may bind in a different manner than the ester series. The tetrahydropyranyl ether 20 showed comparable affinity to 1; thus, monosubstitution of the acetal carbon is better tolerated than disubstitution. There was not a dramatic difference in potency between the epimers of 18; unfortunately, only one epimer of 20 could be isolated, preventing any additional investigation of this question.
The high affinities of the alkoxymethyl ethers are of particular interest because these protecting groups are more stable than acetates under many synthetic conditions. For instance, 1 is readily deacetylated by weak bases, and the a-hydroxy ketone function thus exposed is highly sensitive to strong bases, 12 while MOM ethers are virtually inert under strongly basic conditions. 14 Similarly, MOM ethers are generally more stable to nucleophiles, organometallic and hydride reagents than acetates.
14 A very pertinent illustration of these advantages is the first total synthesis of 1, which employs a BOM protecting group at C-2 in place of the acetate. 28 
Conclusions
It is fortuitous that standard protecting groups, stable and unreactive under a wide range of harsh conditions, should also confer high potency. For synthetic transformations elsewhere in the salvinorin scaffold, this permits the use of conditions incompatible with an acetate or hydroxyl. The resulting derivatives may also possess higher affinity and selectivity than the corresponding acetate, which would be valuable in ameliorating the effects of transformations elsewhere in the parent compound. For instance, some salvinorin derivatives appear to exhibit antagonism or partial agonism, 4,5 but this is accompanied by severe reductions in affinity and selectivity. In such cases, it would be interesting to explore whether a C-2 alkoxymethyl ether substituent attenuated these reductions in affinity and selectivity. Alkoxymethyl ethers are also likely to be more stable in vivo, which would be desirable given salvinorin A's brief duration of action. In a recent report, a MOM ether showed equal in vitro activity against HIV to the corresponding acetate, and greater stability in plasma. 29 
Experimental

General experimental conditions
1 H NMR (300 MHz) and 13 C NMR (75.5 MHz) chemical shifts are referenced to residual solvent peaks as internal standards: CDCl 3 (7.26 and 77 ppm), C 6 D 6 (7.16 and 128 ppm), and C 6 D 5 N (135.5 ppm). 19 F NMR chemical shifts are referenced to CCl 3 F (0 ppm). Where the coupling constants of a discrete multiplet could not be determined, the separation of the outermost peaks (Dm) is given in Hz. Flash column chromatography (FCC) was performed on silica gel (230-400 mesh, 60 Å ), eluting with a stepped gradient over the specified range. Where compound 2 was present due to incomplete reaction or hydrolysis of products, the column was stripped with 20% MeOH/CH 2 Cl 2 to maximize recovery.
Binding assays
Binding affinities at l, d, and j opioid receptors were determined, as previously described, 21 21 Testing was blinded: neither identity nor molecular mass was known to the testers.
Salvinorin B methoxymethyl ether (5)
Prepared as previously described. 13 
Salvinorin B propoxymethyl ether (7)
Propanol was stored over freshly activated 4 Å sieves for 1 h. To a mixture of methylthiomethyl ether 16 (37.6 mg, 83.5 lmol), N-iodosuccinimide (28.6 mg, 127 lmol, 1.5 equiv), and 4 Å molecular sieves (beads) under Ar was added CH 2 Cl 2 (0.5 mL). The flask was cooled to 0°C, and dry propanol (1.5 mL, excess) was added, followed by TfOH (1 lL), and the solution was stirred for 5 min. NaHCO 3 ($100 mg) was added, then the solution was diluted in EtOAc and washed with satd aq NaHCO 3 , 10% aq NaS 2 O 3 , and brine. The organic layer was dried over MgSO 4 
Salvinorin B isopropoxymethyl ether (9)
Procedure as for 7, using 2-propanol. FCC (0-10% EtOAc/CH 2 Cl 2 gradient) gave 9 as a clear resin (18%); TLC (10% EtOAc/CH 2 Cl 2 ): hR f = 27 (9), 41 (16) 
Salvinorin B methylthiomethyl ether (16)
Salvinorin B (2) (32.4 mg, 83 lmol) was dissolved in Me 2 SO (1 mL). AcOH was added (1 mL), followed by Ac 2 O (0.5 mL). The resulting white suspension was stirred at rt for 65 h, giving a clear yellow solution. Aq NaOH (5.0 M, 5 mL) was added drop-wise, then the solution was diluted in EtOAc and washed with satd aq NaHCO 3 (3·) and brine and dried (MgSO 4 
Salvinorin B 1-ethoxyethyl ether (18)
Salvinorin B (2) (49.1 mg, 126 lmol) was dissolved in dry CH 2 Cl 2 (1.5 mL) under Ar and stirred at 0°C. Ethoxyethene (100 lL, 1.04 mmol) and a speck of p-TsOH ((1 mg, catalytic) were added. The resulting suspension was removed from the icebath and stirred at room temperature for 10 min, when it had clarified and turned yellow. TLC (50% EtOAc/hexanes) showed minimal starting material. The solution was diluted in EtOAc and washed with satd aq NaHCO 3 (3·) and dried (MgSO 4 ). Evaporation under reduced pressure and repeated FCC (25-50% EtOAc/hexanes, then 20% MeOH/CH 2 Cl 2 ) gave 18a as an amorphous white solid (20.6 mg, 36%); TLC (50% EtOAc/hexanes): hR f = 48 (18a), 43 (18b), 30 (2); 1 H NMR (C 6 D 6 ): d 7.10 (1H, dt, J = 1.6, 0.9 Hz), 7.05 (1H, t, J = 1.7 Hz), 6.14 (1H, dd, J = 1.9, 0. 
